Use of occlusion device for the local delivery of biologically active dna therapeutic compounds for treating aneurysms and use thereof
CA 2438237 A1 · Owner: Raymond, Jean · Inventors: Leclerc, Guy; Raymond, Jean; Levesque, Luc
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a method for the sustained endovascular treatment of aneurysms, such as intracranial or for closing any body lumen such as , vascular lumen or other using an occlusion device for the local delivery of biologically active DNA therapeutic molecules. The invention also relates to a method for a rapid preparation of the artificial occlusion device to be coated shortly before or during the clinical procedure. A subsequent step in the method of treatment involves introducing at an aneurysm site or inside a vessel a slow-releasing, biologically active DNA molecule-leaching device. The device releases a biologically active DNA molecule at the aneurysm site for …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 22, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 22, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 22, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.